47
Views
7
CrossRef citations to date
0
Altmetric
Review

Transcatheter aortic valve implantation and potential role of 3D imaging

&
Pages 411-421 | Published online: 09 Jan 2014

References

  • Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet368, 1005–1011 (2006).
  • Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J.24, 1231–1243 (2003).
  • Rosamond W, Flegal K, Furie K et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation117(4), E25–E146 (2008).
  • Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J. Am. Coll. Cardiol.50, 1205–1213 (2007).
  • Butany J, Collins MJ, Demellawy DE et al. Morphological and clinical findings in 247 surgically excised native aortic valves. Can. J. Cardiol.21, 747–755 (2005).
  • Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation90, 844–853 (1994).
  • Tanaka K, Sata M, Fukuda D et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol.46, 134–141 (2005).
  • Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J. Am. Coll. Cardiol.23, 1162–1170 (1994).
  • Aikawa E, Nahrendorf M, Sosnovik D et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation115, 377–386 (2007).
  • Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation114, 2065–2069 (2006).
  • Akat K, Borggrefe M, Kaden JJ. Aortic valve calcification – basic science to clinical practice. Heart95(8), 616–623 (2009).
  • Garg V, Muth AN, Ransom JF et al. Mutations in NOTCH1 cause aortic valve disease. Nature437, 270–274 (2005).
  • Kurz DJ, Kloeckener-Gruissem B, Akhmedov A et al. Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arterioscler. Thromb. Vasc. Biol.26, E114–E117 (2006).
  • Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation108, 1804–1808 (2003).
  • Katz R, Wong ND, Kronmal R et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation113, 2113–2119 (2006).
  • Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol.29, 630–634 (1997).
  • Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart78, 472–474 (1997).
  • Novaro GM, Katz R, Aviles RJ et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J. Am. Coll. Cardiol.50, 1992–1998 (2007).
  • Novaro GM, Pearce GL, Sprecher DL, Griffin BP. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J. Heart Valve Dis.10, 19–24 (2001).
  • Otto CM, O’Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart85, 601–602 (2001).
  • Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation113, 861–866 (2006).
  • Wong ND, Sciammarella M, Arad Y et al. Relation of thoracic aortic and aortic valve calcium to coronary artery calcium and risk assessment. Am. J. Cardiol92, 951–955 (2003).
  • Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation110, 1180–1182 (2004).
  • Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation112, I229–I234 (2005).
  • Rosenhek R, Rader F, Loho N et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation110, 1291–1295 (2004).
  • O’Brien KD, Shavelle DM, Caulfield MT et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation106, 2224–2230 (2002).
  • Helske S, Lindstedt KA, Laine M et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J. Am. Coll. Cardiol.44, 1859–1866 (2004).
  • O’Brien KD, Probstfield JL, Caulfield MT et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch. Intern. Med.165, 858–862 (2005).
  • Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res.90, 251–262 (2002).
  • Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation110, 3480–3487 (2004).
  • Pohle K, Maffert R, Ropers D et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation104, 1927–1932 (2001).
  • Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O’Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet359, 1125–1126 (2002).
  • Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation104, 2205–2209 (2001).
  • Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J. Am. Coll. Cardiol.40, 1723–1730 (2002).
  • Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am. J. Cardiol.88, 693–695 (2001).
  • Moura LM, Ramos SF, Zamorano JL et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J. Am. Coll. Cardiol.49, 554–561 (2007).
  • Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med.352, 2389–2397 (2005).
  • Rossebø AB, Pedersen TR, Boman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med.359, 1343–1356 (2008).
  • Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation114, E84–E231 (2006).
  • Svensson LG. Aortic valve stenosis and regurgitation: an overview of management. J. Cardiovasc. Surg. (Torino)49, 297–303 (2008).
  • Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N. Engl. J. Med.328, 1289–1296 (1993).
  • Svensson LG, Deglurkar I, Ung J et al. Aortic valve repair and root preservation by remodeling, reimplantation, and tailoring: technical aspects and early outcome. J. Card. Surg.22, 473–479 (2007).
  • Murtuza B, Pepper JR, Stanbridge RD et al. Minimal access aortic valve replacement: is it worth it? Ann. Thorac. Surg.85, 1121–1131 (2008).
  • Iung B, Vahanian A. Valvular heart diseases in elderly people. Lancet368, 969–971 (2006).
  • Iung B, Cachier A, Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J.26, 2714–2720 (2005).
  • Alexander KP, Anstrom KJ, Muhlbaier LH et al. Outcomes of cardiac surgery in patients ≥80 years: results from the National Cardiovascular Network. J. Am. Coll. Cardiol.35, 731–738 (2000).
  • Mihaljevic T, Nowicki ER, Rajeswaran J et al. Survival after valve replacement for aortic stenosis: implications for decision making. J. Thorac. Cardiovasc. Surg.135, 1270–1278 (2008).
  • Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann. Thorac. Surg.82, 2111–2115 (2006).
  • Bouma BJ, van Den Brink RB, van Der Meulen JH et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart82, 143–148 (1999).
  • Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann. Thorac. Surg.82, 2116–2122 (2006).
  • Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J. Am. Coll. Cardiol.50, 2018–2019 (2007).
  • Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur. Heart J.9(Suppl. E), 57–64 (1988).
  • Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. Am. J. Cardiol.78, 97–101 (1996).
  • Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am. Heart J.99, 419–424 (1980).
  • Kapadia SR, Goel SS, Svensson Let al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J. Thorac. Cardiovasc. Surg.137(6), 1430–1435 (2009).
  • O’Neill WW. Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. J. Am. Coll. Cardiol.17, 193–198 (1991).
  • Berland J, Cribier A, Savin T, Lefebvre E, Koning R, Letac B. Percutaneous balloon valvuloplasty in patients with severe aortic stenosis and low ejection fraction. Immediate results and 1-year follow-up. Circulation79, 1189–1196 (1989).
  • Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation89, 642–650 (1994).
  • Lieberman EB, Bashore TM, Hermiller JB et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J. Am. Coll. Cardiol.26, 1522–1528 (1995).
  • Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur. Heart J.13, 704–708 (1992).
  • Cribier A, Eltchaninoff H, Tron C et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J. Am. Coll. Cardiol.43, 698–703 (2004).
  • Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation114, 1616–1624 (2006).
  • Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol.50, 69–76 (2007).
  • Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation114, 591–596 (2006).
  • Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation113, 842–850 (2006).
  • Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation116, 755–763 (2007).
  • Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation106, 3006–3008 (2002).
  • Descoutures F, Himbert D, Lepage L et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur. Heart J.29, 1410–1417 (2008).
  • Vahanian A, Alfieri O, Al-Attar N et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio–Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J.29, 1463–1470 (2008).
  • Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation118, 1864–1880 (2008).
  • Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann. Biomed. Eng.34, 1799–1819 (2006).
  • Kaplan AV, Baim DS, Smith JJ et al. Medical device development: from prototype to regulatory approval. Circulation109, 3068–3072 (2004).
  • Vassiliades TA Jr, Block PC, Cohn LH et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). J. Thorac. Cardiovasc. Surg.129, 970–976 (2005).
  • Zegdi R, Khabbaz Z, Borenstein N, Fabiani JN. A repositionable valved stent for endovascular treatment of deteriorated bioprostheses. J. Am. Coll. Cardiol.48, 1365–1368 (2006).
  • Roselli EE, Greenberg RK, Pfaff K, Francis C, Svensson LG, Lytle BW. Endovascular treatment of thoracoabdominal aortic aneurysms. J. Thorac. Cardiovasc. Surg.133, 1474–1482 (2007).
  • Vesely I. Heart valve tissue engineering. Circ. Res.97, 743–755 (2005).
  • Rieder E, Seebacher G, Kasimir MT et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation111, 2792–2797 (2005).
  • Sacks MS, Engelmayr GC, Hildebrand D. Bioreactors for heart valve tissue engineering. In: Bioreactors for Tissue Engineering. Chaduri J, Al-Rubeai M (Eds). Springer, Dordrecht, The Netherlands, 235–267 (2005).
  • Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during development and remodeling of cardiac valves. J. Heart Valve Dis.13, 841–847 (2004).
  • Hoerstrup SP, Sodian R, Daebritz S et al. Functional living trileaflet heart valves grown in vitro. Circulation102(19 Suppl. 3), III44–III49 (2000).
  • Sutherland FWH, Perry TE, Yu Yet al. From stem cells to viable autologous semilunar heart valve. Circulation111, 2783–2791 (2005).
  • Brody S, Pandit A. Approaches to heart valve tissue engineering scaffold design. J. Biomed. Mater. Res. B Appl. Biomater.83, 16–43 (2007).
  • Dohmen PM, Lembcke A, Holinski S et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann. Thorac. Surg.84, 729–736 (2007).
  • Simon P, Kasimirr MT, Seebacher Get al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Eur. J. Cardiothorac Surg.23, 1002–1006 (2003).
  • Fann JI, Chronos N, Rowe SJet al. Evolving strategies for the treatment of valvular heart disease: preclinical and clinical pathways for percutaneous aortic valve replacement. Catheter. Cardiovasc. Interv.71, 434–440 (2008).
  • Hufnagel CA, Harvey WP, Rabil P et al. Surgical correction of aortic valve insufficiency. Surgery35, 673–680 (1954).
  • Non-orthotopic Model for Stentless Heart Valve Evaluation. From the Office of Science and Technology – Annual Report – Fiscal Year 1995. US FDA Center for Devices and Radiological Health, MD, USA (1995).
  • Petersilka M, Bruder H, Krauss B, Stierstorfer K, Flohr TG. Technical principles of dual source CT. Eur. J. Radiol.68, 362–368 (2008).
  • Choo SJ, McRae G, Olomon JP et al. Aortic root geometry: pattern of differences between leaflets and sinuses of Valsalva. J. Heart Valve Dis.8, 407–415 (1999).
  • Rankin JS, Dalley AF, Crooke PS, Anderson RH. A ‘hemispherical’ model of aortic valvar geometry. J. Heart Valve Dis.17, 179–186 (2008).
  • Lansac E, Lim HS, Shomura Y et al. Aortic root dynamics are asymmetric. J. Heart Valve Dis.14, 400–407 (2005).
  • Lansac E, Lim HS, Shomura Y et al. A four-dimensional study of the aortic root dynamics. Eur. J. Cardiothorac Surg.22, 497–503 (2002).
  • Kazui T, Izumoto H, Yoshioka K, Kawazoe K. Dynamic morphologic changes in the normal aortic annulus during systole and diastole. J. Heart Valve Dis.15, 617–621 (2006).
  • Kazui T, Kin H, Tsuboi J, Yoshioka K, Okabayashi H, Kawazoe K. Perioperative dynamic morphological changes of the aortic annulus during aortic root remodeling with aortic annuloplasty at systolic and diastolic phases. J. Heart Valve Dis.17, 366–370 (2008).
  • Tops LF, Wood DA, Delgado V et al. Noninvasive evaluation of the aortic root with multislice computed tomography: implications for transcatheter aortic valve replacement. J. Am. Coll. Cardiol. Img.1, 321–330 (2008).
  • Delgado V, Bax JJ. Classical methods to measure aortic valve area in the era of new invasive therapies: still accurate enough? Int. J. Cardiovasc. Imaging.25(2), 183–185 (2009).
  • Doddamani S, Grushko MJ, Makaryus AN et al. Demonstration of left ventricular outflow tract eccentricity by 64-slice multi-detector CT. Int. J. Cardiovasc. Imaging.25(2), 175–181 (2009).
  • Pérez de Isla L, Zamorano J, Pérez de la Yglesia R et al. [Quantification of aortic valve area using three-dimensional echocardiography]. Rev. Esp. Cardiol.61, 494–500 (2008).
  • Zegdi R, Ciobotaru V, Noghin M et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J. Am. Coll. Cardiol.51, 579–584 (2008).
  • Poh KK, Levine RA, Solis J et al. Assessing aortic valve area in aortic stenosis by continuity equation: a novel approach using real-time three-dimensional echocardiography. Eur. Heart J.29(20), 2526–2535 (2008).
  • Burgstahler C, Kunze M, Loffler C, Gawaz MP, Hombach V, Merkle N. Assessment of left ventricular outflow tract geometry in non-stenotic and stenotic aortic valves by cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson.8, 825–829 (2006).
  • Okura H, Yoshida K, Hozumi T et al. Planimetry and transthoracic two-dimensional echocardiography in noninvasive assessment of aortic valve area in patients with valvular aortic stenosis. J. Am. Coll. Cardiol.30, 753–759 (1997).
  • John AS, Dill T, Brandt RR et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standard. J. Am. Coll. Cardiol.42, 519–526 (2003).
  • Willmann JK, Weishaupt D, Lachat M et al. Electrocardiographically gated multi-detector CT for assessment of valvular morphology and calcifications in aortic stenosis. Radiology225, 120–128 (2002).
  • Herzog C, Nasreddin A, Balzer J et al. Heart-rate-adapted image reconstruction in multidetector-row cardiac CT: influence of physiological and technical prerequisite on image quality. Eur. Radiol.12, 2670–2678 (2002).
  • Feuchtner GM, Dichtl W, Friedrich GJ et al. Multislice computed tomography for detection of patients with aortic valve stenosis and quantification of severity. J. Am. Coll. Cardiol.47, 1410–1417 (2006).
  • Alkadhi H, Desbiolles L, Husmann L et al. Aortic regurgitation: assessment with 64-section CT. Radiology245, 111–121 (2007).
  • Feuchtner GM, Muller S, Grander W et al. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis. J. Heart Valve Dis.15, 494–498 (2006).
  • Feuchtner GM, Dichtl W, Schachner T et al. Diagnostic performance of MDCT for detecting aortic valve regurgitation. Am. J. Roentgenol.186, 1676–1681 (2006).
  • Morgan-Hughes GJ, Owens PE, Roobottom CA, Marshall AJ. Three dimensional volume quantification of aortic valve calcification using multislice computed tomography. Heart89, 1191–1194 (2003).
  • Morgan-Hughes GJ, Roobottom CA. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin. Radiol.59, 208(2004).
  • Budoff MJ, Takasu J, Katz R et al. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. Acad. Radiol.13, 166–172 (2006).
  • Akhtar M, Tuzcu ME, Kapadia SR et al. Aortic root morphology in patients undergoing percutaneous aortic valve replacement. evidence of aortic root remodeling. J. Thoracic Cardiovasc. Surg.137(4), 950–956 (2009).
  • Maselli D, De Paulis R, Scaffa Ret al. Sinotubular junction size affects aortic root geometry and aortic valve function in the aortic valve reimplantation procedure: an in vitro study using the Valsalva graft. Ann. Thorac. Surg.84, 1214–1218 (2007).
  • Rodés-Cabau J, Dumont E, De Larochellière R et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am. J. Cardiol.102, 1240–1246 (2008).
  • Murray D, Ghosh J, Khwaja N, Murphy MO, Baguneid MS, Walker MG. Access for endovascular aneurysm repair. J. Endovasc. Ther.13, 754–761 (2006).
  • Kurra V, Schoenhagen P, Roselli EE et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography. J. Thorac. Cardiovasc. Surg.137(5), 1258–1264 (2009).
  • Eide KR, Odegard A, Myhre HO, Haraldseth O. Initial observations of endovascular aneurysm repair using Dyna-CT. J. Endovasc. Ther.14, 50–53 (2007).
  • Teutelink A, Muhs BE, Vincken KL et al. Use of dynamic computed tomography to evaluate pre- and postoperative aortic changes in AAA patients undergoing endovascular aneurysm repair. J. Endovasc. Ther.14, 44–49 (2007).
  • Eggebrecht H, Heusch G, Erbel R, Ladd ME, Quick HH. Real-time vascular interventional magnetic resonance imaging: the future of aortic stent-graft placement? Basic Res. Cardiol.102, 1–8 (2007).
  • Peterson BG, Longo GM, Matsumura JS et al. Endovascular repair of thoracic aortic pathology with custom-made devices. Surgery138, 598–605 (2005).
  • Greenberg RK, Haddad F, Svensson L et al. Hybrid approaches to thoracic aortic aneurysms: the role of endovascular elephant trunk completion. Circulation112, 2619–2626 (2005).
  • Schachner T, Feuchtner G, Bonaros N et al. Does preoperative multislice computed tomography predict operative times in total endoscopic coronary artery bypass grafting? Heart Surg. Forum.8, E314–E318 (2005).
  • Falk V, Mourgues F, Adhami L et al. Cardio navigation: planning, simulation, and augmented reality in robotic assisted endoscopic bypass grafting. Ann. Thorac. Surg.79, 2040–2047 (2005).
  • Chiu AM, Dey D, Drangova M, Boyd WD, Peters TM. 3-D image guidance for minimally invasive robotic coronary artery bypass. Heart Surg. Forum3, 224–231 (2000).
  • Sato Y, Kamata J, Izumoto H, Nasu M, Kawazoe K. Morphological analysis of aortic root in eccentric aortic regurgitation using anyplane two-dimensional images produced by transesophageal three-dimensional echocardiography. J. Heart Valve Dis.12, 186–196 (2003).
  • Laissy JP, Messika-Zeitoun D, Serfaty JM et al. Comprehensive evaluation of preoperative patients with aortic valve stenosis: usefulness of cardiac multidetector computed tomography. Heart93, 1121–1125 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.